See All Resources

Home > Resources > Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio- Oncology Society

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio- Oncology Society

Go to Resource
Share:

Link is copied!

Get Certified

See All Certifications
A white doctor and a black doctor discuss the test results

Cardio-Oncology Knowledge

Go To Certification
A map of the world
Chapters

North America

Europe

Asia + Oceania

South America

Africa